While this is the licensed indication, it's important to note that NICE guidance (TA875) recommends more specific criteria for NHS use: typically for people with a BMI 35 kg/m (lower thresholds may apply for some ethnic groups) with at least one weight-related comorbidity, prescribed within specialist weight management services, and limited to a maximum treatment duration of 2 years
Int J Prev Med 2022;13:95
Conversely, adding 1.2 mL instead of 1.0 mL dilutes to 8.33 mg/mL, and every dose is about 17% weaker than planned
Cmo conservar la pluma KwikPen de Mounjaro Para que tu pluma precargada se mantenga en perfecto estado, ten en cuenta lo siguiente: Mantn la pluma Mounjaro en su caja original hasta el momento de usarla
How Can I Find It Near Me
and A sodium-glucose co-transporter-2 (SGLT2) inhibitor has been trialled and discontinued due a contraindication or intolerance or due to not achieving a clinically meaningful response